| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1588 |
| Trial ID | NCT02685670 |
| Disease | Chronic Lymphocytic Leukemia | Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma |
| Year | 2016 |
| Country | China |
| Company sponsor | The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine |
| Other ID(s) | DHHUTCM20160106 |
| Cohort 1 | |||||||||||
|
|||||||||||